SAB Biotherapeutics Inc (SABS): Bozor kapitallashuvi
SAB Biotherapeutics (SABS) daromadlari immunoterapiyani ishlab chiqish bo'yicha AQSh hukumati buyurtmalari va shifoxona shartnomalariga asoslangan bo'lib, bozor kapitalizatsiyasi 0.28 ni tashkil etadi. O'zgarishlarni aniq ko'rsatuvchi ushbu narxlar grafigi donorlar ishtirokisiz poliklonal antitanalarni sintez qilish imkonini beruvchi DiversitAb platformasining salohiyatini tasdiqlaydi. Biznesning barqarorligi bioximiklardan iborat barqaror shtat va noyob patologiyalar bo'yicha ekspertlarni faol jalb qilish orqali mustahkamlanmoqda.
SAB Biotherapeutics Inc (SABS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning kapitalga nisbati SAB Biotherapeutics|SABS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati SAB Biotherapeutics|SABS - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati SAB Biotherapeutics Inc|SABS - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi SAB Biotherapeutics|Tezkor likvidlik koeffitsiyenti sabbiotherapeutics.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
SABS - Sof foyda|Kelajakdagi foyda SAB Biotherapeutics|SABS - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori SAB Biotherapeutics, Inc|SABS - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati SAB Biotherapeutics Inc|SABS - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda SAB Biotherapeutics|SABS - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi sabbiotherapeutics.com|SABS - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi SAB Biotherapeutics
Kompaniyaning fundamental tahlili:SABS (SAB Biotherapeutics, Inc.)
Antikorlarni tashish paytida sovuq zanjirning ishonchliligi SAB Biotherapeutics kompaniyasining operatsion barqarorligini belgilaydi. Kompaniyaning umumiy bozor kapitallashuvi barcha muomaladagi aksiyalarning umumiy bozor qiymatini ifodalaydi. Ushbu metrikaning dinamikasi bozorning biznesning miqyoslanishiga bo'lgan ishonchini aks ettiradi. Umumiy bozor kapitallashuvi egri chizig'ini tahlil qilish spekulyativ shovqinni fundamental o'sishdan ajratish imkonini beradi. Mavjud tendentsiya aktivning adolatli qiymatini aniqlash uchun asos bo'lib xizmat qiladi.
Muhim raqobatchilar
Bozor kapitallashuvi ARGX (argenx)|Bozor kapitallashuvi BioNTech Inc. BNTX|Abivax S.A. - Bozor kapitallashuvi|ADMA: Bozor qiymati|Protagonist Therapeutics (PTGX) - Bozor qiymati|IMVT - Bozor kapitallashuvi|Bozor qiymati Kiniksa|Grifols SA - Bozor bahosi|Bozor kapitallashuvi ADPT|CLDX (Celldex Corp) - Bozor qiymati|Bozor kapitallashuvi AUPH (Aurinia Pharmaceuticals)|Bozor kapitallashuvi biocryst.com BCRX|VERA - Bozor qiymati|Bozor qiymati DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Bozor qiymati|Bozor bahosi AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi precigen.com|Bozor bahosi PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Bozor qiymati|Bozor kapitallashuvi UPB (Upstream Bio Corp)|Bozor kapitallashuvi Zenas Corp (ZBIO)|IMNM - Bozor qiymati|gossamerbio.com (GOSS) - Bozor bahosi|KalVista Pharmaceuticals, Inc. (KALV) - Bozor qiymati|Bozor bahosi Septerna, Inc.|Bozor bahosi PVLA|Bozor kapitallashuvi Savara Pharma|Bozor qiymati Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Bozor kapitallashuvi|Bozor kapitallashuvi ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Bozor qiymati|RAPT - Bozor qiymati|Bozor kapitallashuvi Aerovate Therapeutics Inc JBIO|ACRS: Bozor kapitallashuvi|kyvernatx.com (KYTX) - Bozor kapitallashuvi|TLSA (Tiziana Life Sciences Ltd) - Bozor kapitallashuvi|Bozor qiymati CABA|Bozor bahosi VTYX (Ventyx Bio)|THTX (Theratechnologies, Inc) - Bozor qiymati|Bozor kapitallashuvi AVTX (Avalo Therapeutics, Inc)|eledon.com - Bozor qiymati|Agenus Inc. - Bozor kapitallashuvi|Bozor kapitallashuvi Climb Bio Inc. CLYM|Zura Bio (ZURA) - Bozor qiymati|Bozor qiymati aTyr Pharmaceuticals (ATYR)|Bozor bahosi ADAG|IMA (Ikena Oncology, Inc.) - Bozor qiymati|Bozor kapitallashuvi STTK|EQ (equilliumbio.com) - Bozor qiymati|Bozor kapitallashuvi CNTB (Connect Biopharma Holdings Limited)|Immunic Therapeutics (IMUX) - Bozor qiymati|ATRA - Bozor qiymati|Bozor qiymati IFRX (InflaRx N.V.)|XFOR: Bozor kapitallashuvi|Adicet Bio, Inc. (ACET) - Bozor kapitallashuvi|Bozor qiymati Celularity Inc|INmune Bio Corporation - Bozor bahosi|Bozor kapitallashuvi BRNS|KZR - Bozor qiymati|Akari Therapeutics Plc - Bozor bahosi|Bozor kapitallashuvi Enlivex Therapeutics Ltd ENLV|QTTB: Bozor bahosi|GeoVax Corp - Bozor qiymati|EDSA: Bozor kapitallashuvi|IBIO - Bozor kapitallashuvi|CARM (Carisma Therapeutics Inc) - Bozor kapitallashuvi|Bozor bahosi XTL Biopharmaceuticals Ltd (XTLB)|Bozor qiymati Bolt Biotherapeutics (BOLT)|Bozor kapitallashuvi hcwbiologics.com|Bozor qiymati Aptevo Therapeutics Inc. APVO|Bozor kapitallashuvi aimimmuno.com (AIM)|Aditxt Corp - Bozor kapitallashuvi|GRI - Bozor kapitallashuvi|XRTX: Bozor kapitallashuvi|HIND (Vyome Therapeutics) - Bozor qiymati|Bozor qiymati Revelation Biosciences|indaptusrx.com (INDP) - Bozor kapitallashuvi|Bozor qiymati Scinai Immunotherapeutics Ltd. (SCNI)|CALI: Bozor bahosi|Bozor kapitallashuvi AFMD (Affimed N.V.)|Bozor qiymati ALLK|HOOKIPA - Bozor kapitallashuvi|IGMS - Bozor kapitallashuvi|iTeos Therapeutics, Inc. (ITOS) - Bozor qiymati|Ocean Biomedical Inc - Bozor qiymati|Bozor qiymati TC BioPharm (Holdings) PLC|Bozor bahosi Third Harmonic Bio Inc (THRD)
